The Department of Veterans Affairs is seeking to award a sole-source IDIQ contract to Natera, Inc. for specialized molecular residual disease testing services for transplant patients and cancer monitoring. This is a special notice for planning purposes, and interested parties can submit capability statements demonstrating equivalent proprietary testing capabilities.
Prospera molecular expression transplant assessment test (CPT Code 81479)
25
Each
$3,000.00
$75,000.00
Medical
Estimated Bid Value
$180,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus the 1 document, contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.